A two-strain tuberculosis model with general contact rate which allows tuberculosis patients with the drug-sensitive Mycobacterium tuberculosis strain to be treated is presented. The model includes both drug-sensitive and drug-resistant strains. A detailed qualitative analysis about positivity, boundedness, existence, uniqueness and global stability of the equilibria of this model is carried out. Analytical results of the model show that the quantities R 1 and R 2 , which represent the basic reproduction numbers of the sensitive and resistant strains, respectively, provide the threshold conditions which determine the competitive outcomes of the two strains. Numerical simulations are also conducted to confirm and extend the analytic results.
Introduction
Tuberculosis TB , an infectious disease caused by Mycobacterium tuberculosis M. tuberculosis , is one of the world's leading causes of infectious mortality. According to the World Health Organization WHO , one third of the world's population is infected with M. tuberculosis, leading to between two and three millions death each year. At present, about 95% of the estimated 8 million new cases of TB occurring each year are in developing countries, where 80% occur among people between the ages of 15 and 59 years 1 . For the time being, TB is becoming a world-wide problem. War, famine, homelessness, and a lack of medical care all contribute to the increasing incidence of tuberculosis among disadvantaged persons. Since TB is easily transmissible between persons, the increase in TB in any segment of the population represents a threat to all segments of the population. Sub-Saharan Africa remains the epicenter of the epidemic, but India, China, Indonesia, Bangladesh and Pakistan together account for more than half of the cases in the world 2 . TB was assumed to be on its way out in developed countries until the number of TB cases began to increase in the 1980s. With this return, we face the paradox of a well-known bacteria, fully treatable with efficient and affordable drugs according to internationally recommended guidelines, which yet causes increasing human suffering and death. Active TB cases may be pulmonary or extrapulmonary, but pulmonary cases are more infectious and form the bulk of most cases of active TB. The usual symptoms of active TB include fatigue, high fever, night sweats, loss of appetite, and a cough, but confirmation of active TB requires a positive sputum culture. Extrapulmonary accounts for between 5% and 30% of the total cases and may affect any part of the body. M. tuberculosis droplets are released into the air by sneezing and coughing of infectious individuals. Tubercle bacillus carried by such droplets live in the air for a short period of time 3 ; it is believed that occasional contacts with an infectious individual rarely lead to transmission. TB is described as a slow disease because of its long and variable latency period distribution and its short and relatively narrow infectious period distribution. Individuals who are latently infected are neither clinically ill nor capable of transmitting TB 4 . Most latently infected individuals do not become infectious active TB . About 5%-10% of the latently infected individuals develop active TB, that is, about 90%-95% remain latently infected.
Antituberculosis drugs are a two-edged sword. While they destroy pathogenic M. tuberculosis, they also select for drug-resistant bacteria against with those drugs which are then ineffective. Global surveillance has shown that drug-resistant TB is widespread and is now a threat to TB control programs in many countries. The WHO distinguishes between two types of resistance: acquired resistance-resistance among previously treated patients; and primary resistance-resistance among new cases. In all regions studied, prevalence of acquired resistance is higher than prevalence of primary resistance, but the size of this difference varies between regions 5 . Treatment of TB consists of a combination of different drugs to avoid acquisition of resistance. Despite these precautions, drug resistance continues to emerge being favoured by the long duration of treatment and improper use of the antibiotics. Drug resistant TB has higher rates of treatment failure and longer periods of infectiousness in part due to the time lapse between TB diagnosis and obtaining drug-sensitivity test results 6 . In general, tuberculosis can be treated with antibiotics. However, most worrisome is resistance to the two first-line drugs, isoniazid and rifampicin, defined as multidrug resistance MDR -TB, which is an emerging problem of great importance to public health, with higher mortality rates than drug-sensitive TB, particularly in immunocompromised patients. MDR-TB patients require treatment with more toxic second line drugs and remain infectious for longer than patients infected with drugsensitive strains, incurring higher costs due to prolonged hospitalization.
Mathematical models can provide useful tools to analyze the spread and control of infectious diseases 7 . Different mathematical models for TB have been formulated and studied 3, 5, [8] [9] [10] [11] [12] [13] [14] [15] [16] . In most of the epidemics models for TB discussed in the literature, the question of contact rate has not been a central one. Nevertheless, the mode of transmission is crucially important for two reasons. First, it determines the probable response of the disease to control, second, the objective in many models of disease in animals is to predict what will happen when a pathogen is introduced into a system in which it does not currently exist 17 . Even more important, several laboratory studies have found that the mass action incidence rate is inadequate for describing pathogen transmission and standard incidence rate is considered, for human disease, more accurate than mass action incidence rate 17 . Moreover, epidemic models with nonlinear incidence rate have recently attracted a great deal of attention from mathematical models 18-22 . In fact, the incidence of a disease which is the number of new cases per unit time plays an important role in the study of mathematical epidemiology. Thieme and Castillo-Chavez 23 argued that the general form of a population-size-dependent incidence should be written as βC N SI/N, where S and I are the numbers of susceptible and infective at time t, respectively, β is the probability of transmitting the infection between two individuals taking part in a contact per unit time, C N is the probability for an individual to take part in a contact and N is the size of the total population. In 24 , Zhang and Ma think the above incidence frequently takes two forms in most of the literature. When C N N, the corresponding incidence is the bilinear form βNSI/N βSI. When C N λ, the corresponding incidence λSI/N is called standard form. When the total population size N is not quite large, since the number of contacts made by an individual per unit time should increase as the total population size N increases, the bilinear form would be suitable, but when the total population size is too large, since the number of contacts made by an infective per unit time should be limited, or should grow less rapidly as the total population size N increases, the bilinear form is not suitable and the standard form may be more realistic 24 . Therefore, the two forms of incidence mentioned above are actually two extreme cases for the total population size N being very small and very large, respectively. Moreover, Heesterbeek and Metz 25 derived the expression for the saturating contact rate of individuals contacts in a population that mixes randomly, that is,
where C N is nondecreasing and C N /N is nonincreasing. In Bowong and Tewa 26 , a SEI type of tuberculosis model with a general contact rate is proposed to study the global asymptotically stability of disease-free equilibrium and endemic equilibrium. The stability of equilibria is derived through the use of Lyapunov stability theory and LaSalle's invariant set theorem. Nevertheless, the effect of drugresistant strain of tuberculosis is not taken into account in their article. In this paper, we study a tuberculosis model with general contact rate that includes explicitly both drugsensitive strain and drug-resistant strain. We adapt the approach of Bowong and Tewa 26 for modeling the effective chemoprophylaxis given to latently infected individuals and therapeutic treatments given to infectious . We extend their model by including the latently infected with resistant strain class and infectious with resistant strain class. The new model allows us to examine the effects of drug treatment on the prevalence of both drug-sensitive and drug-resistant strains. Mathematical properties of the model system are studied both analytically and numerically. It is shown that the system has three possible equilibrium points including an endemic equilibrium at which both strains are present. A detailed analysis of global asymptotically stability is conducted, which shows that the dynamic behaviors of the system are determined by two quantities, R 1 and R 2 , which represent the basic reproduction numbers of the sensitive and resistant strains. Without regard to disease-induced death rate, we prove that the disease-free equilibrium is globally asymptotically stable when R 1 < 1, R 2 < 1, the unique drug-resistant-TB-strain-only equilibrium exists and is globally asymptotically stable when R 1 < 1 < R 2 . As for the unique interior equilibrium, existence, uniqueness and global stability can be proved under certain conditions. The paper is organized as follows. In Section 2, we formulate a two-strain tuberculosis model with general contact rate. The threshold conditions for the existence and uniqueness equilibria are derived and the global asymptotically stability of equilibria are proved in Sections 3 and 4 is devoted to numerical simulations. In Section 5, we summarize the findings and conclusions.
Model Description
According to the transmitted features of TB, we subdivide the population into susceptible individuals S , those exposed to drug-sensitive TB E 1 , individuals with symptoms of TB and drug-sensitive I 1 , those exposed to drug-resistant TB E 2 and those displaying symptoms of TB and drug-resistant I 2 , the total number of population at time t is given by
The model is represented by the transfer diagram in Figure 1 . Here, Λ is the recruitment rate, μ is nondisease related death rate. Since exposed individuals are not capable of transmitting the disease, we assume that susceptible may become infected only through contacts with active infectious individual at a rate β i N I i , i 1, 2, where i 1 and i 2 represent rates of infection by drug-sensitive strain and drug-resistant strain, and the transmission coefficient β i N is a nonnegative C 2 function of the total population N. Susceptible are infected with drug-sensitive strain and drug-resistant strain entering classes E 1 and E 2 , respectively. For simplicity, we only account for treatment of sensitive strain, we assume that chemoprophylaxis of individuals in E 1 reduces their reactivation at a constant rate r 1 and that the initiation of therapeutics immediately removes individuals in I 1 from active status and places them into exposed class at a constant rate r 2 . The time before individuals in E 1 who does not received effective chemoprophylaxis become infectious is assumed to satisfy an exponential distribution, with mean waiting time 1/k 1 . Thus, individuals leave the class E 1 to the class I 1 at a constant rate k 1 1 − r 1 . The time before individuals in E 2 become infectious is also assumed to satisfy an exponential distribution, with mean waiting time 1/k 2 . Thus, individuals leave the class E 2 to the class I 2 at a constant rate k 2 . Individuals sick with drugsensitive strain receive treatment at rate r 2 and a proportion pr 2 respond to treatment and move into exposed class E 1 , in the remaining proportion 1 − p r 2 , inappropriate treatment results in the development of drug-resistant strain and the individuals move into class E 2 . Individuals in the infectious class I 1 and I 2 suffer additional disease-induced death at rate d 1 and d 2 , where d 2 > d 1 . Then the following two strains tuberculosis model is formulated
where Λ, k 1 , k 2 , r 1 , and r 2 are assumed to be positive and p ∈ 0, 1 . It is natural to assume that the transmission coefficient β 1 N , β 2 N satisfies the following conditions:
2.3
Abstract and Applied Analysis Obviously, we can see that β 1 N β 1 /N, β 2 N β 2 /N corresponds to the standard incidence rate, that β 1 N β 1 , β 2 N β 2 corresponds to the mass action incidence rate, and that β 1 N β 1 C N , β 2 N β 2 C N corresponds to the saturating contact rate, where
Positivity and Boundedness
System 2.2 describes human population and therefore it is necessary to prove that all the variables S, E 1 , I 1 , E 2 , I 2 are nonnegative for all time. Solutions of system 2.2 with positive initial data remains positive for all time t ≥ 0 and are bounded. 
Proof. Under the given initial conditions, it is easy to prove that the solutions of the system 2.2 are positive; if not, we assume a contradiction: that there exists a first time t 1 such that
there exists a t 2
there exists a t 3
Abstract and Applied Analysis there exists a t 4
or there exists a t 5
In the first case, we have
which is a contradiction meaning that S t ≥ 0, t ≥ 0. In the second case, we have
which is a contradiction meaning that E 1 t ≥ 0, t ≥ 0. In the third case, we have
which is a contradiction meaning that I 1 t ≥ 0, t ≥ 0. In the fourth case, we have
which is a contradiction meaning that E 2 t ≥ 0, t ≥ 0. In the fifth case, we have
which is a contradiction meaning that
be any solution with nonnegative initial condition, adding all equations in system 2.2 gives
2.16
It follows that
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where N 0 represents initial values of the total population. Thus 0 ≤ N t ≤ Λ/μ, as t → ∞. Therefore all feasible solutions of system 2.2 enter the region
Hence, Γ is positively invariant and it is sufficient to consider solutions of system 2.2 in Γ. Existence, uniqueness and continuation results for system 2.2 hold in this region. It can be shown that N t is bounded and all the solutions starting in Γ approach, enter or stay in Γ.
Model Analysis
There are one disease-free equilibrium P 0 and two possible endemic equilibria for system 2.2 , the endemic equilibria include boundary equilibrium P 1 when only the drug-resistant TB-strain is present and the interior equilibrium P 2 when both strains exist .
Global Stability of the Disease-Free Equilibrium
The disease-free-equilibrium is given as
The basic reproduction number is defined as the number of secondary infections produced by a single infectious individual during the entire infectious period. In our case the reproduction number defines the number of secondary TB infections produced by a single active TB individual during the entire infectious period. Mathematically it is defined as the spectral radius of the next generation matrix 27 . To determine the stability of the disease-free steady state P 0 , we use the results in van den Driessche and Watmough 27 . Reorder the components of P 0 as E 1 0,
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The infected compartments are E 1 , I 1 , E 2 , and I 2 . Thus
The dominant eigenvalues of FV −1 are given by
where R 1 and R 2 are reproduction numbers for drug-sensitive TB strain only and drugresistant TB strain only, respectively. It implies that the spectral radius of the matrix FV
If R 1 < 1, and R 2 < 1, then ρ FV −1 < 1. By Theorem 3.2 in van den Driessche and Watmough 27 , we know that the disease-free steady state P 0 is locally asymptotically stable, P 0 is unstable if R 1 > 1 or R 2 > 1. The following theorems provide the global stability of the disease-free equilibrium.
To conduct an analytical analysis of global asymptotical behaviors of the disease-free equilibrium point, first of all, we assume that there is no disease-induced death rate, that is, 
3.6
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Notice that the S equation is eliminated from 3.6 and the variable S is replaced by S 0 − E 1 − I 1 − E 2 − I 2 . By introducing the fractions
we obtain the equivalent limiting system from 3.6
3.8
Obviously
for all time t ≥ 0. For a bounded real-valued function f on 0, ∞ , we define 
for n → ∞.
Theorem 3.2.
In the absence of disease-induced death rate, the disease-free equilibrium P 0 of system 2.2 is globally asymptotically stable if
Proof. By Lemma 3.1 and the x 2 , y 2 equations in 3.8 we have
Using the x 1 equation in 3.8 and choosing t n → ∞ such that
Abstract and Applied Analysis we get
3.14
It is shown that x
0. The inequalities in 3.12 also imply that x ∞ 2 0. Using the y 1 equation in 3.8 and choosing s n → ∞ such that
we get
3.16
It is shown that y
0. The inequalities in 3.12 also imply that y
Therefore, the disease-free equilibrium P 0 is globally asymptotically stable.
Next, we consider that there is disease-induced death rate, which means that d 1 > 0, d 2 > 0. Then, we can get the following theorem.
Proof. Let us consider the following Lyapunov function:
Its time derivative along the solutions of system 2.2 satisfieṡ
3.19
Now, using 2.3 , one has
3.20
Since
and 
Existence and Uniqueness of the Drug-Resistant-TB-Strain-Only Equilibrium
Here, we present a result concerning the existence and uniqueness of the drug-resistant-TB-strain-only equilibrium for the system 2.2 . To do this, we shall make use of the basic reproduction ratio R 1 and R 2 . Let P 1 S, 0, 0, E 2 , I 2 be boundary equilibrium of system 2.2 . Then, the boundary equilibrium can be obtained by setting the right-hand side of each differential equations in system 2.2 equal to zero with the exception of second and third equation, giving
adding the above three equations, we have
Using 3.24 , the first and second equation of 3.23 , we can easily express S, E 2 and I 2 in terms of N in the form:
3.25
Substituting S, E 2 , I 2 in the third equations of 3.23 yields
where
3.27
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Clearly, Λ − μ N 0 is a fixed point of 3.23 , which corresponds to the disease-free equilibrium P 0 . Since N ∈ 0, S 0 , we get
3.28
It appears that F 0 < 0 and F S 0 > 0 when R 2 > 1. 
Global Stability of the Drug-Resistant-TB-Strain-Only Equilibrium
Theorem 3.5. If R 1 < 1 < R 2 , the drug-resistant-TB-strain-only equilibrium P 1 exists and is locally asymptotically stable.
Proof. Reorder the equilibrium P 1 as 0, 0, E 2 , I 2 , S . Similarly as in the proof of locally stability of the disease-free steady state P 0 , we have
14
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The spectral radius of
3.31
Since β 1 N N ≥ 0, and N ≤ S 0 , then
As R 1 < 1, we have ρ F 1 V −1 1 < 1, which implies that the drug-resistant-TB-strain-only equilibrium P 1 is locally asymptotically stable by Theorem 3.2 in van den Driessche and Watmough 27 .
The following theorem provides the global stability of drug-resistant-TB-strain-only equilibrium.
Theorem 3.6. If there is no disease-induced death rate, the drug-resistant-TB-strain-only equilibrium
Proof. If R 1 < 1 < R 2 , from Theorem 3.5, P 1 is locally asymptotically stable. In the following, we only need to prove that the P 1 is a global attractor.
There is no disease-induced death rate, which means d 1 d 2 0, using a similar argument as in the proof of Theorem 3.2, we can show that if R 1 < 1,
Then the equivalent limiting system of 3.6 is
3.35
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Let P, Q be the vector field defined by system 3.35 . Then for the Dulac function D E 2 , I 2 1/E 2 I 2 , there holds
From Dulac's criterion, we can see equivalent limiting system 3.35 does not have a limit cycle. Therefore, the local stability of P 1 implies the global stability in Int Γ. This completes the proof of Theorem 3.6.
Existence and Uniqueness of the Interior Equilibrium
First of all, we assume that
then, existence, uniqueness and global stability of interior equilibrium can be obtained. Let
2 be interior equilibrium of system 2.2 . Then, the interior equilibrium steady state with I 1 > 0, I 2 > 0 can be obtained by setting the right-hand side of each of the five differential equations in system 2.2 equal to zero, giving
adding the above five equations, we have
Using 3.37 and 3.38 , we get the following equivalent equations set
16
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3.40
0, N * satisfies the following equation:
3.42
It means that G N * 0 has only one positive root in the interval 0, S 0 if G N * is monotone increasing and G S 0 ≥ 0, which is equivalent to
3.44
3.46
When
it shows that G S 0 ≥ 0, and G N * is monotone increasing, by the intermediate valuetheorem, G N * 0 has only one positive root in the interval 0, S 0 , which signify that P 2 is unique. Obviously, S * > 0. In order to make certain that E *
Due to d 2 > d 1 > 0, introducing 3.40 into 3.48 , we acquire
and B 1 < B 2 . Now, we can get the following conclusion.
Remark 3.8. For β 1 N β 1 and β 1 N β 1 /N, condition W 1 is not satisfied. However, at least when β 1 N β 1 C N , condition W 1 is satisfied, we also can find our conclusions are still correct from Figures 7 and 10. 
Global Stability of the Interior Equilibrium
Herein, we study the global stability of the interior equilibrium P 2 of system 2.2 . For simplicity, we only consider the special case when the transmission coefficients of drugsensitive TB-strain and drug-resistant TB-strain are equal, that is, β 1 N β 2 N β N , then, we get the following result. 
3.51
Proof. Following 33 , we consider the Lyapunov function:
3.52
where C and D are positive constants to be determined later. Differentiating this function with respect to time along the solutions of system 2.2 yieldṡ
pr 2 I * 1
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3.56
Then, 3.55 can be rewritten as follows:
3.57
Now, let 
It shows that the disease-free equilibrium P 0 is stable. Figures 2, 3 , and 4 show the trajectories plots and their plane figures, respectively, which are in agreement with Theorem 3.2.
When there is disease-induced death rate, which means that d 1 > 0, d 2 > 0, we take d 1 0.02, d 2 0.07. Firstly, we consider system 2.2 with β 1 N β 1 , β 2 N β 2 and choose β 1 β 2 0.001, so that R 1 < 1, R 2 < 1, Figure 5 presents the trajectories plot and plane figure. From this figure, we can see that the trajectories of system 2.2 converge to the disease-free 
It shows that the disease-free equilibrium P 0 is stable. 
It shows that the disease-free equilibrium P 0 is stable. equilibrium. We also choose β 1 0.001, β 2 1, so that R 1 < 1, R 2 > 1, Figure 6 presents the trajectories plot and plane figure. It shows that the drug-resistant-TB-strain-only equilibrium is global asymptotically stable. Then, we choose β 1 1, β 2 0.25, so that R 1 > H, R 2 < f R 1 , the trajectories plot and its plane figure are depicted in Figure 7 , we can observe that the trajectories converge to the unique interior equilibrium. This implies that both the sensitive and resistant strains coexist and prevail in the host population as shown in Theorem 3.9.
Next, we need to think the case when Figures 8, 9 and 10 show the trajectories plot and its plane figure of system 2.2 when β 1 β 2 0.001 so that R 1 < 1, R 2 < 1 , β 1 0.001, β 2 1 so that R 1 < 1, R 2 > 1 , and β 1 
.07, so that R 1 < 1, R 2 < 1. It shows that the disease-free equilibrium P 0 is stable. that R 1 > H, R 2 < f R 1 , respectively. As the previous cases, we can find that the trajectories of system 2.2 converge to the disease-free equilibrium when R 1 < 1, R 2 < 1 see Figure 8 , the drug-resistant-TB-strain-only equilibrium is global asymptotically stable when R 1 < 1, R 2 > 1 see Figure 9 , while the trajectories of system 2.2 converge to the unique interior equilibrium when R 1 > 1, R 2 < f R 1 see Figure 10 . Eventually, we assume that β 1 N β 1 C N , β 2 N β 2 C N , C N bN/ 1 bN √ 1 2bN in system 2.2 , of which b 1. Numerical results are depicted in Figures 11, 12 , and 13. Figure 11 presents the trajectories and its plane figure when β 1 β 2 0.001 so that R 1 < 1, R 2 < 1 . From this figure, it clearly appears that the disease disappears in the host population. Figure 12 that R 1 < 1, R 2 > 1 , we can see that the drug-resistant-TB-strain-only equilibrium is global asymptotically stable. Figure 13 gives a description of the trajectories and its plane figure when β 1 1, β 2 0.25 so that R 1 > H, R 2 < f R 1 . By observation, we conclude that both the sensitive and resistant strains will coexist and prevail in the host population. It shows that the interior equilibrium P 2 is stable.
Discussion
In this paper, we studied a two-strain tuberculosis model that includes both drug-sensitive and drug-resistant strains. The novelty of our model is that we incorporate general contact rate β i N , i 1, 2 into a two-strain tuberculosis model. By using the Lyapunov stability theory, LaSalle's invariant set theorem and Dulac's criterion, the global stability of equilibria of the proposed model is proved. The basic reproduction number R 1 , R 2 provide the threshold conditions which determine the competitive outcomes of the two strains. When R 1 < 1, R 2 < 1, the disease-free equilibrium P 0 is globally stable and the disease will die out. When R 1 < 1, R 2 > 1, a unique boundary equilibrium P 1 exists and is globally stable. While when R 1 > H, R 2 < f R 1 , there exists a unique interior equilibrium P 2 which is globally asymptotically stable under certain conditions. A fairly good agreement is obtained between the analytical and numerical results.
With the appearance of numerous second-line antituberculous drugs, such as capreomycin, amikacin, and kanamycin, the treatment of drug-resistant-TB has become possible. We will leave this for future study.
